CellChem Pharmaceuticals Ondansetron Product Recall (2019-10-16)
- Starting date:
- October 16, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-71337
Last updated: 2019-10-18
Summary
-
Product:
A. CCP-Ondansetron 8 mg Tablet;B. CCP-Ondansetron 4 mg Tablet
A. CCP-Ondansetron 8 mg Tablet;
B. CCP-Ondansetron 4 mg Tablet
Reason
Affected lot is labelled with the incorrect indication found on the inner label.
Depth of distribution
Retailers
Affected products
A. CCP-Ondansetron 8 mg Tablet
DIN, NPN, DIN-HIM
DIN 02458802
Dosage form
Tablet
Strength
Ondansetron 8 mg
Lot or serial number
409424
Companies
- Recalling Firm
-
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
- Marketing Authorization Holder
-
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
B. CCP-Ondansetron 4 mg Tablet
DIN, NPN, DIN-HIM
DIN 0245880
Dosage form
Tablet
Strength
Ondansetron 4 mg
Lot or serial number
409423
Companies
- Recalling Firm
-
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA
- Marketing Authorization Holder
-
Cellchem Pharmaceuticals Inc
Unit 1, 30 Concourse Gate,
Ottawa
K2E 7V7
Ontario
CANADA